This website is intended for healthcare professionals only
Specialities

Specialities

Artificial Intelligence
Anterior Segment
Cataract Surgery
Corneal and External Disorders
COVID-19
Diabetic Macular Edema
Diabetic Retinopathy
Glaucoma
Imaging
Macular Degeneration
Neuro-ophthalmology
Ocular Oncology
Ocular Surface Disease
Oculoplastic Surgery
Pediatric Ophthalmology
Refractive Surgery
Retina/Vitreous
Ocular Immunology
Rare Disease Day
Posterior Segment
Search

Trending Topic

Macro shot of eye featuring holographic HUD graphics layered over pupil and cornea, neon light accents and sharp reflections, high tech cyber vision theme, ultra detailed 8k
7 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Advancing Keratoconus Management: ECO-CAIRS, Biomechanics and the Evolution of Corneal Allogenic Intrastromal Ring Segments

Emilio A Torres-Netto, Mark Hillen, Farhad Hafezi

Corneal ectatic disorders, such as keratoconus, progressively weaken corneal integrity, leading to thinning, irregular astigmatism and visual deterioration.1 Typically progressive in nature, these ectasias result in increasingly thinner corneas, causing the cornea to protrude forward into a cone shape. This leads to increasing amounts of myopia and astigmatism – both regular and irregular – as the disease […]

touchREVIEWS in Ophthalmology. 2026;20(1):1–4:Online ahead of journal publication

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

Kyoko Ohno-Matsui, EURETINA 2022: Anomalies of choroidal venous structures in high myopia

03:39
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Sep 20th 2022

In this interview on her EURETINA presentation, Prof. Kyoko Ohno-Matsui (Tokyo Medical and Dental University, Tokyo, Japan) discussed choroidal venous structures and how they change in myopic eyes.

‘Anomalies of choroidal venous structures in high myopia’ was presented at EURETINA 2022, 1–4 September 2022  

  1.     What is known about the choroidal structures in myopic eyes? (00:20)
  2.     What were the aims, design  and eligibility criteria of your study? (01:07)
  3.     What changes were found in highly myopic eyes? (01:55)
  4.     What is the clinical significance of these findings? (02:35)

Disclosure: Kyoko Ohno-Matsui has nothing to disclose in relation to this video.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.

Filmed as a highlight of EURETINA 2022.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

ARVO 2026: DME data spotlight longer durability, IL-6 inhibition and emerging dual-pathway therapies

Arshad M Khanani, Roger Goldberg, Monica Loevestam-Adrian

At the ARVO 2026 Annual Meeting, DME remained a major focus, with multiple studies exploring how clinicians may extend treatment intervals, improve outcomes in suboptimal responders and target inflammatory pathways beyond VEGF. Across phase 2 and phase 3 trials, as well as real-world observational studies, key themes included long-term durability with faricimab, sustained-delivery approaches, and growing evidence supporting dual-pathway strategies that may help address the heterogeneity of DME in routine practice.

Advertisement

    • Related Videos in Retina/Vitreous

    Latest articles videos and clinical updates - straight to your inbox

    Close Popup